Skip to main content

Inhalon Biopharma Receives $7 Million from USAMRDC to Study Inhaled “Muco-trapping” Antibody for the Treatment of COVID-19: Sam Lai Article

October 1, 2021
Inhalon Biopharma, a start-up immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating a variety of acute respiratory infections (ARI), today announced that it has been awarded a $7 million contract by the U.S. Army Medical Research & Development Command (USAMRDC) to conduct a placebo-controlled Phase 1/2a study of...

Antibodies Stop Sperm in Their Tracks: Sam Lai Article

October 1, 2021
Currently, most available birth control options are barrier methods or rely on hormones to prevent fertilization of an egg—both of which have drawbacks, such as discomfort or side effects, that make them less than ideal for some people. Enter antisperm antibodies, described in a study published today (August 11) in...

Dr. Jason Whitmire awarded DoD Investigator-Initiated Research Award

September 22, 2021
Jason Whitmire, PhD (Professor, Department of Genetics, Department of Microbiology & Immunology), was awarded a Peer Reviewed Medical Research Program (PRMRP) Investigator-Initiated Research Award by the US Army Medical Research Acquisition Activity of the Department of Defense (DoD). This four year award titled “Pathogenic T Cells in Guillain Barre Syndrome”,...

M&I Faculty and Scientists Collaborate with UNC Program in Nicaragua

February 7, 2020
UNC has expanded its partnership with the Universidad Nacional Autónoma de Nicaragua-León (UNAN) to include the development of a PhD program housed at UNAN. Many M&I faculty, trainees and staff recently participated in the PhD program, including Aravinda de Silva, PhD, Ralph Baric, PhD, Helen Lazear, PhD, Nilu Goonetilleke, PhD,...

Former M&I Graduate Student, Kizzmekia Corbett, Developing a Vaccine against the Coronavirus

January 30, 2020
Kizzmekia Corbett, who graduated with her Ph.D. from UNC Microbiology and Immunology in 2014, is the scientific lead for a project at the National Institute of Health (NIH) to develop a vaccine against the new Coronavirus.